⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRCT News
PROCEPT BioRobotics Corporation Common Stock
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES
prnewswire.com
PRCT
Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
prnewswire.com
SWAV
PRCT
ISRG
GDT
Bronstein, Gewirtz & Grossman, LLC Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders to Inquire about Securities Investigation
accessnewswire.com
PRCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
accessnewswire.com
PRCT
Bronstein, Gewirtz & Grossman, LLC Is Investigating PROCEPT BioRobotics Corporation (PRCT) And Encourages Shareholders to Connect
accessnewswire.com
PRCT
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
globenewswire.com
PRCT
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Shareholders to Reach Out
accessnewswire.com
PRCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
accessnewswire.com
PRCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT
accessnewswire.com
PRCT
Bronstein, Gewirtz & Grossman, LLC Encourages PROCEPT BioRobotics Corporation (PRCT) Stockholders to Inquire about Securities Investigation
accessnewswire.com
PRCT